0 followers
Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.
Industries
Headquarters
Stage
Employees
Links
Nickolay V. Kukekov
View all
0 members
PharmaCielo
1 follower
Charlie Health
2 followers
Cannara Biotech
Aphria
3 followers
Khiron Life Sciences
Explore more companies